Regulatory

Latest News

laboratory for biosimilar development | Image credit: 201606422 - stock.adobe.com
Biosimilar Market Development Requires Strategic Flexibility and Global Partnerships

April 29th 2025

Thriving in the evolving biosimilar market demands bold collaboration, early global partnerships, and a fresh approach to development strategies to overcome uncertainty and drive future success.

eye on pharma banner
Eye on Pharma: Sandoz Files Antitrust Suit; Yuflyma Interchangeability; Costco’s Ustekinumab Pick

April 22nd 2025

laboratory | image credit: Cavan -stock.adobe.com
BioRationality: EMA Accepts Waiver of Clinical Efficacy Testing of Biosimilars

April 21st 2025

white house  | Image credit: Vacclav - stock.adobe.com
President Trump Signs Executive Order to Bring Down Drug Prices

April 16th 2025

united states | Image credit: warmworld - stock.adobe.com
How State Substitution Laws Shape Insulin Biosimilar Adoption

April 15th 2025

Video Interviews
Podcasts
CFB podcast banner
CFB podcast banner
CFB podcast banner
CfB Podcast Banner
"SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars" with the CfB logo and an image of an eye
CfB podcast banner
CfB podcast banner
podcast banner
image of adalimumab biosmilar eveloped by alvotech prefilled syring
canadian flag on a mountain

More News

© 2025 MJH Life Sciences

All rights reserved.